Intracorporeal Versus Extracorporeal Anastomotic After Laparoscopic Right Colectomy
Colon Cancer
About this trial
This is an interventional treatment trial for Colon Cancer focused on measuring laparoscopic, intracorporeal anastomosis, anastomotic leak
Eligibility Criteria
Inclusion criteria
- Age: 18 ~ 80 years, male or female;
- Histological or cytological diagnosis of right colon cancer (cecum, ascending colon and proximal 1/3 of the transverse colon cancer);
- Stage I-III according to the AJCC-TNM classification including downstaged tumor based on adequate imaging of the thorax and abdomen;
- Intention for right hemicolectomy (including extended right hemicolectomy) with primary anastomosis;
- Informed consent according to local requirements Exclusion criteria
1) T4b tumor determined by CT scan; 2) Malignancy other than adenocarcinoma at histological examination ; 3)Other malignancies in medical history, except adequately treated basocellular carcinoma of the skin or in situ carcinoma of the cervix uteri; 4) Previous history of colorectal cancer or synchronous multiple colorectal malignancies; 5) Complications requiring emergency surgery (obstruction, perforation, etc); 6) Planned synchronous abdominal organ resections; 7) Pregnant or lactating women; 8) Familial Adenomatosis Polyposis Coli (FAP), active Crohn's disease or active ulcerative colitis; 9) Absolute contraindication to general anesthesia or laparoscopic surgery.
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
Intracorporeal anastomotic after LRC
Extracorporeal anastomotic after LRC